Pharmaceutical Research & Manufacturers of America v. Thompson

D.C. Circuit

Pharmaceutical Research & Manufacturers of America v. Thompson

321 F.3d 1134, 355 U.S. App. D.C. 189, 2003 U.S. App. LEXIS 4007, 2003 WL 1191463

CourtCourt of Appeals for the D.C. Circuit

DecidedMarch 5, 2003

DocketNo. 02-5110

StatusPublished

This text of 321 F.3d 1134 (Pharmaceutical Research & Manufacturers of America v. Thompson) is published on Counsel Stack Legal Research, covering Court of Appeals for the D.C. Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Pharmaceutical Research & Manufacturers of America v. Thompson, 321 F.3d 1134, 355 U.S. App. D.C. 189, 2003 U.S. App. LEXIS 4007, 2003 WL 1191463 (D.C. Cir. 2003).

Pincite

Opinion

PER CURIAM.

ORDER

Upon consideration of federal appellees’ petition for rehearing filed February 7, 2003, it is

ORDERED that the petition be granted. It is

FURTHER ORDERED that the opinion in Pharmaceutical Research and Manufacturers of America v. Thompson, 313 F.3d 600 (D.C.Cir.2002), be amended as follows:

Delete the last sentence of the second paragraph, “We therefore reverse the judgment of the District Court and .enter judgment for PhRMA.”

Insert in lieu thereof:

The judgment is reversed and the case is remanded for entry of an appropriate judgment by the District Court.

Delete the last clause of the last paragraph of the opinion. The last paragraph of the opinion now reads:

For the aforementioned reasons, the judgment of the District Court is hereby reversed and the case remanded for entry of an appropriate judgment.

Free access — add to your briefcase to read the full text and ask questions with AI